Top Cannabis Investment News, Member Posts, Cannabis Investment Daily Indices and more!

1mo ago Cannabis blunttruthlaw Views: 192

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana.

Congress removed marijuana banking from the COMPETES Act.  In other federal news, a House Appropriations committee passed a cannabis-friendly amendment to a DOJ funding bill.  Meanwhile, in Nebraska, signature collecting continues for a ballot initiative.  Turning our attention abroad, Switzerland considers changes to its medical marijuana rules.  And finally, Major League Baseball welcomes CBD sponsors.

safe banking

If sponsors of the SAFE Banking Act are feeling like Sisyphus right about now, one can hardly blame them.  With each new Congress comes a new introduction of this bill that would allow cannabis businesses to use the banking system.  And in each Congress, the bill remains “just a bill.”  The most recent defeat for the legislation came late last week, when the provision was dropped from the COMPETES Act.  But hey – a new Congress starts in January…

doj spending bill

This week, however, brought some more promising news for the cannabis industry.  The House Appropriations Committee passed an amendment to the FY23 Commerce, Justice, Science and Related Agencies spending bill prohibiting the agency from using money to prosecute those in cannabis-legal states.  Congresswoman Barbara Lee (D-CA) called the move “critically important.”

nebraska

Supporters of a medical marijuana ballot initiative in Nebraska have until July 7 to collect signatures, and it looks as if this will come down to the wire.  Advocates have gathered approximately 60,000 signatures for each of two initiatives, but need another 50,000 per petition to ensure they can qualify.  A 2020 drive gathered sufficient signatures, but was deemed to contain more than one subject and tossed off the ballot.

switzerland

In other medical cannabis news, the Swiss seem likely to change rules governing their medical marijuana industry.  Patients would no longer need a special government permit and could get a prescription from their doctor.  Businesses welcome the change, believing that it will allow them to expand their offerings.

and finally

If you’re looking to try something other than “peanuts and Cracker Jack” when you head out to the “old ball game,” Major League Baseball (MLB) has news for you.  Earlier this month, MLB approved CBD companies as team sponsors.  Products must be certified not to have psychoactive levels of THC and be approved by the Commissioner’s office.

Stay safe and be well everyone – we’ll see you next week!


Today's Cannabis Investment Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.